.@sciotobio and Abigail Wexner Research Institute at @nationwidekids Receive a $2.3MM Phase II #SBIR Grant to Develop Novel Therapy https://t.co/3rxFN4m8Yu
Excited for @sciotobio and @nationwidekids, recipients of a $2.3M @NIH grant supporting development of an extended-release probiotic treatment for necrotizing enterocolitis. #microbiome
Our client @sciotobio will present at the Microbiome Movement - Maternal & Infant Health Summit in Boston May 24th highlighting its Activated Bacterial Therapeutic platform and its ability to promote a healthy infant #microbiome. #guthealth https://t.co/rcCSBXyMUB
Excited to have our CSO, Mark Heiman, present at the Microbiome Movement - Maternal and Infant Health Summit in Boston!
https://t.co/HVEGZdmCME
@MicrobiomeTimes@MicrobiomeDaily
We are excited to help roll out @sciotobio’s new website! An emerging biotech company, Scioto is developing an innovative platform for the delivery of #microbiome therapeutics #biotech#guthealth. Check it out: https://t.co/1GZZJBlFjv
We are excited to launch our new website! From its sleek design elements, to its streamlined content, the site is easy to navigate, mobile friendly and more. Thanks to @LaVoieGroup and @DelinDesign Check it out: https://t.co/O8A8DtJ0PC
@microbiome@NECsociety
Kudos to James Schulz '19, Alex Johnson '19, & Dayem Adnan '20, who presented papers Friday at the Indiana Political Science Association conference in Indianapolis. According to Dr. Ethan Hollander, their work stood shoulder to shoulder with both professors and grad students.
.@sciotobio presentation of data @AAPexperieNCE shows reduction of incidence and severity of experimental C. diff infection and improved survival in mice using its its novel live bacterial therapeutics delivery platform. #microbiome https://t.co/iu19a42KP5
#Microbiome company Scioto Biosciences is turning a longstanding enemy of antibiotics developers -- biofilms -- into a delivery vehicle for probiotics. Find out how here @BioCentury https://t.co/vhFf0VIG5w
#JHMI are looking forward to participating in the @US_FDA and #NIAID public #microbiome workshop next month. Covering the science and regulation of live microbiome-based products, we’re especially interested in clinical and manufacturing aspects! https://t.co/9P1s8Oc3lf